University College London in partnership with National institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre has located translational research projects and spin-outs at its laboratories in SBC. These projects have high commercialization potential and cover a broad range of technologies in drug discovery and medical devices. UCL is driven to engage more closely with the biotechnology and pharmaceutical industries in SBC’s open innovation environment for developing therapeutic solutions to improve patients’ health and quality of life.

Follow @ucl

Hear how UCL research is helping level the playing field in our latest #MadeAtUCL podcast about accessibility, diversity in advertising, and legal support for those in need: bit.ly/3mFyYh4 #MadeAtUni @IOE_London @JessicaRingrose @GDIHub @GiuliaBar86 @UCLLaws @UCLCAJ pic.twitter.com/91gWBl65EL

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.